TUMOR-NECROSIS-FACTOR ENHANCES THE INVITRO AND INVIVO EFFICACY OF CHEMOTHERAPEUTIC DRUGS TARGETED AT DNA TOPOISOMERASE-II IN THE TREATMENT OF MURINE BLADDER-CANCER

被引：53

作者：

ALEXANDER, RB

ISAACS, JT

COFFEY, DS

机构：

[1] JOHNS HOPKINS UNIV,SCH MED,DEPT UROL,BALTIMORE,MD 21205

[2] JOHNS HOPKINS UNIV HOSP,JAMES BUCHANAN BRADY UROL INST,BALTIMORE,MD 21205

来源：

关键词：

D O I：

10.1016/S0022-5347(17)43178-8

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：427 / 429

页数：3

共 14 条

[1] AGGARWAL BB, 1985, METHOD ENZYMOL, V116, P448
[2] ALEXANDER RB, 1987, CANCER RES, V47, P2403
[3] CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN
BEUTLER, B
CERAMI, A
[J]. NATURE, 1986, 320 (6063) : 584 - 588
[4] BLICK M B, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P14
[5] ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS
CARSWELL, EA
OLD, LJ
KASSEL, RL
GREEN, S
FIORE, N
WILLIAMSON, B
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) : 3666 - 3670
[6] INTRAVESICAL DOXORUBICIN FOR PROPHYLAXIS IN THE MANAGEMENT OF RECURRENT SUPERFICIAL BLADDER-CARCINOMA
GARNICK, MB
SCHADE, D
ISRAEL, M
MAXWELL, B
RICHIE, JP
[J]. JOURNAL OF UROLOGY, 1984, 131 (01) : 43 - 46
[7] KHAN A, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P226
[8] TUMOR NECROSIS FACTOR (TNF)
OLD, LJ
[J]. SCIENCE, 1985, 230 (4726) : 630 - 632
[9] RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR .2. ANTITUMOR EFFECT ON MURINE AND HUMAN-TUMORS TRANSPLANTED IN MICE
SOHMURA, Y
NAKATA, K
YOSHIDA, H
KASHIMOTO, S
MATSUI, Y
FURUICHI, H
[J]. INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1986, 8 (03): : 357 - 368
[10] SOLOWAY MS, 1977, CANCER RES, V37, P2918